10x Genomics (TXG) Amortization of Deferred Charges (2025 - 2026)

10x Genomics (TXG) posted Amortization of Deferred Charges of $2.0 million for Q1 2026, up 8.98% sequentially from $1.8 million in Q1 2025, and up 8.98% YoY from $1.8 million in Q1 2025.

10x Genomics (TXG) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

10x Genomics has reported Amortization of Deferred Charges for 2 years, with the latest figure at $2.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Privia Health 2.78 Bn 2.42 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.02 Mn
Jun 30, 2026 2.02 Mn
Mar 31, 2026 1.95 Mn
Mar 31, 2026 1.95 Mn
Mar 31, 2025 1.79 Mn
Mar 31, 2025 1.79 Mn